Sales decline 22.93% to Rs 6.25 crore
Net profit of Beryl Drugs declined 30.19% to Rs 0.37 crore in the quarter ended June 2024 as against Rs 0.53 crore during the previous quarter ended June 2023. Sales declined 22.93% to Rs 6.25 crore in the quarter ended June 2024 as against Rs 8.11 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var.Sales6.258.11 -23 OPM %15.8413.93 -PBDT0.781.01 -23 PBT0.500.73 -32 NP0.370.53 -30Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
